Difference between revisions of "Parkin"
m |
|||
| Line 44: | Line 44: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | |
| + | |- | ||
| + | |Video | ||
| + | |{{#ev:dailymotion|7ebyfxNw2r8XekXX0|300}} | ||
| + | |- | ||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 13:11, 14 September 2007
| Template:Infobox header| Parkin | |
|---|---|
| |
| Substrate peptide name | Parkin |
| Synonyms | Ubiquitin E3 ligase PRKN |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | O60260 |
| Reactive glutamines | - |
| Reactive lysines | K49 |
| Substrate sequence | VIFAGKELRND |
| Structure | 1IYF |
| Surface accessibility | ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:15132984 |
| Notes | |
| Video | 7ebyfxNw2r8XekXX0|300}} |
| Template:Infobox header | | |
